RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES
Clinical trials for RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES trials appear
Sign up with your email to follow new studies for RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug candidate tested for tough blood cancers
Disease control Recruiting nowThis early-stage study tests the safety of a drug called trichostatin A in adults with blood cancers that have returned or not responded to standard treatments. About 42 participants will receive the drug to find the highest safe dose and identify side effects. The goal is not a …
Matched conditions: RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES
Phase: PHASE1 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 04:36 UTC
-
New hope for tough blood cancers: experimental drug QLS2309 enters human testing
Disease control Recruiting nowThis early-phase study tests an experimental drug called QLS2309 in about 186 adults with CD70-positive blood cancers that have returned or not responded to standard therapy. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. Parti…
Matched conditions: RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES
Phase: PHASE1 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 13:51 UTC